Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Oxaprozin - Generic Drug Details

« Back to Dashboard
Oxaprozin is the generic ingredient in three branded drugs marketed by Gd Searle, Sandoz, Actavis Elizabeth, Sun Pharm Inds Inc, Ivax Sub Teva Pharms, Mylan Pharms Inc, Watson Labs, Teva, Mylan, Dr Reddys Labs Ltd, and Apotex Inc, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for oxaprozin. Twenty-three suppliers are listed for this compound.

Summary for Generic Name: oxaprozin

Drug Master File Entries: see list13
Suppliers / Packaging: see list23
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Drug Prices:see low prices

Clinical Trials for: oxaprozin

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc
TABLET;ORAL075987-001Sep 2, 2004RXNo
Gd Searle
TABLET;ORAL018841-004Oct 29, 1992RXYes
Sun Pharm Inds Inc
TABLET;ORAL075844-001Jan 3, 2002RXNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.